Poniard Pharmaceuticals, Inc. (PARD) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	1.98M
Cash - restricted	22K
Investment securities	0
Prepaid expenses and other current assets	246K
Total current assets	2.25M
Facilities and equipment, net of depreciation of $778 and $745 at June 30, 2011 and December 31, 2010, respectively	18K
Licensed products, net of amortization of $6,230 and $5,623 at June 30, 2011 and December 31, 2010, respectively	5.47M
Total assets	7.74M
Accounts payable	1.48M
Accrued liabilities	1.5M
Total current liabilities	2.98M
Capital lease obligations, noncurrent portion	1.64M
Total long-term liabilities	1.64M
Commitments and contingencies	0
Preferred stock, $0.02 par value, 2,998,425 shares authorized: Convertible preferred stock, Series 1, 78,768 shares issued and outstanding as of June 30, 2011 and December 31, 2010 (entitled in liquidation to $1,985)	2K
Common stock, $0.02 par value, 200,000,000 shares authorized: 59,859,271 and 48,547,896 shares issued and outstanding as of June 30, 2011 and December 31, 2010, respectively	1.2M
Additional paid-in capital	451.88M
Other comprehensive income	0
Accumulated deficit	-449.96M
Total shareholders' equity	3.12M
Total liabilities and shareholders' equity	7.74M

Entities mentioned with PARD

View All Entities